Bertold Emmerich

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

The French Cooperative Group on CLL, S.A. Johnson, Alex Smith et al. · The Lancet · 1996 · 438 citations

Medicine, Immunology, Oncology +10

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer et al. · Blood · 2009 · 333 citations

Medicine, Oncology, Pharmacotherapy +7

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)

C.‐M. Wendtner, Matthias Ritgen, C D Schweighofer et al. · Leukemia · 2004 · 268 citations

Pharmacy, Oncology, Pharmacotherapy +17

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

Michael Hallek, Irmgard Langenmayer, Christoph Nerl et al. · PubMed · 1999 · 236 citations

Medicine, Hematology, Oncology +9

Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature

Annette Lebeau, Evelyn Zeindl‐Eberhart, Eva‐Christina Müller et al. · Blood · 2002 · 171 citations

Medicine, Molecular Medicine, Pathology +9